Roche Launches New Cobas Pro Integrated Solutions to Significantly Reduce Manual Operations in Labs

Publisher: The Insight Partners

Roche launched cobas pro integrated solutions is now available for countries accepting the CE mark. This next generation of innovation in the Serum Work Area marks a significant milestone in evolving laboratory diagnostic workflow and continues with Roche’s long tradition as leader in lab consolidation.

F. Hoffmann-La Roche Ltd. is a company operates its business functions in the field of pharmaceuticals and diagnostics, making it a pivotal company in personalized healthcare. The company provides medicines across fields such as, immunology, ophthalmology, infectious diseases and disease of the central nervous systems. Roche’s revenue are generated from two business segments namely, Pharmaceuticals and Diagnostics. Other business areas covered under diagnostics are Tissue Diagnostics, Molecular Diagnostics, Centralized and Point of Care Solutions, & Diabetes Care. For the further development, the company has signed 41 agreements of partnerships with other players.

In the point of care diagnostics market, the company offers its products and services under the business category of diagnostics segment. Molecular Diagnostics, tissue diagnostics, diabetic care and centralized and point of care solutions are covered under the business segment of diagnostics. The company is headquartered in Switzerland and has its operations Mannheim, Penzberg, Grenzach-Wyhlen, and Waiblingen, Remseck-Aldingen and Kornwestheim.